In the healthcare landscape of 2026, the conversation has shifted from the anticipation of AI's arrival to its rapid integration. As adoption increases, the focus on ensuring reliability and proper governance of these artificial intelligence systems is more crucial than ever. Understanding the capabilities of an AI model is vital, but equally important is the assurance that health systems can effectively implement and maintain these technologies. This stage is critical and hinges on the integrity of patient data, which serves as the backbone for successful AI deployment.
The safety of AI systems is directly tied to robust data quality management and governance. This gives rise to two fundamental questions regarding data quality in healthcare AI: First, is the data used for developing and validating AI models reliable? Second, is the real-time patient data the models engage with accurate, comprehensive, current, and associated with the correct individual? Relying on mere confidence is insufficient; in the next 12 to 18 months, healthcare providers can expect a closer integration of data quality initiatives with AI approval protocols, where substandard data may formally halt or delay AI rollouts.
According to a survey conducted by the American Medical Association in March 2026, 81% of physicians now utilize some form of AI in their practice, a significant increase from 38% in 2023. It’s important to clarify that this doesn’t mean that 81% are engaging in AI-assisted medical practice; rather, they are recognizing AI's utility in everyday clinical tasks. This includes activities such as summarizing research and treatment protocols (39%), generating discharge instructions and care plans (30%), and documenting billing codes and patient notes (28%).
The shift towards routine use of automation in administrative functions and workflows signals a significant trend. Nevertheless, the journey is far from complete. Innovations in generative AI are making inroads into electronic health records (EHR), while predictive AI is enhancing operational areas like risk assessment for re-admissions and identifying high-risk patients, along with scheduling and billing optimizations. Moreover, diagnostic AI, which encompasses computer vision and machine learning algorithms, has been integrated into medical device operations for some time.
For healthcare systems to be truly ready for AI integration, it is essential to rely on precise, accurate, and continuously updated data. The risks associated with flawed data quality can lead to catastrophic errors. For instance, if an AI system incorrectly prescribes a medication due to inaccurate dosage information, the consequences could be dire. Similarly, incorrect metadata regarding drug administration routes can result in administering potentially dangerous doses.
Other potential pitfalls include inaccurate risk assessments, misrouted health alerts, and false eligibility determinations. These issues can lead to financial losses, damage to trust in healthcare systems, delays in care, wrongful treatments, or even fatalities.
Duplicate patient records pose significant challenges for both healthcare research and clinical practice, with some analysts estimating a duplication rate of 8-10%. This means that a healthcare system with one million patient records could be grappling with 80,000 duplicates, complicating cost management and the accuracy of AI-driven decisions. Further complicating matters, fragmented records can elevate risks associated with AI applications, such as missing critical medications or contraindicated supplements.
Before an AI system can accurately interpret a patient's medical history, healthcare organizations must establish trust in the records associated with that patient. Techniques like identity resolution, record matching, and deduplication play a crucial role in creating a reliable, unified patient record. These practices not only enhance the quality of care but also serve to ensure that the data used in AI processes is solid.
Some of the most significant safeguards for AI technologies can be established well before the algorithms are applied. Solutions from companies like Melissa assist in achieving compliance with initiatives like Project US@. This project, overseen by the Office of the National Coordinator for Health Information Technology (ONC), standardizes patient address data to minimize inconsistencies in identifying information that can lead to fragmented or duplicated records.
Thus, data quality infrastructure must be treated as integral to AI infrastructure. An exceptional AI model could still yield inaccurate results if the data it processes does not accurately reflect patient realities. Consequently, issues such as duplicate records, wrong identities, and outdated medical information can have amplified repercussions in an AI context.
Building a robust data foundation doesn’t require healthcare organizations to overhaul their existing data environments. A simple checklist can guide the process through all stages of data quality, starting from the beginning and extending to ongoing data oversight:
1. Validate and standardize identity attributes during patient registration, ensuring alignment with Project US@ standards. 2. Resolve and deduplicate data across EHR, claims, and ancillary systems prior to feeding that data into AI models. 3. Assess the consistency and currency of clinical data fields that AI utilizes, such as medications, allergies, and coverage information. 4. Maintain vigilant monitoring of identity discrepancies and address them as AI-related incidents, rather than relegating them to routine administration. 5. Include evidence of data integrity in the AI evaluation process alongside model performance metrics.
Readiness for AI involves more than treating data quality as an intermittent task. Healthcare organizations must implement continuous mechanisms for profiling, validating, cleansing, and monitoring data as it flows in and changes throughout its lifecycle. Tools offered by Melissa, for instance, can facilitate these processes across various entry points and existing data workflows, ensuring that healthcare organizations can fully trust their patient data before AI systems are engaged in clinical decision-making.
About the Author
Bob Stanley, who leads special projects at Melissa, aids clients in effectively managing the data lifecycle for insights in business, pharmaceutical, and clinical contexts. To connect with Bob, reach out via email at [email protected] or find him on LinkedIn.
